Table 2.
AMX | TZP | CAZ | FEP | MEM | LVX | GEN | TOB | AMK | ERY | CLI | SXT | VAN | RIF | CST | OXA | LZD | MIN | PEN | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Patient 1 | |||||||||||||||||||
S. epidermidis | R | R | R | S | R | R | R | S | S | R | S | S | |||||||
P. aeruginosa | R | R | R | R | R | I | S | R | S | ||||||||||
Patient 2 | |||||||||||||||||||
S. epidermidis | S | R | R | S | R | S | S | S | S | R | S | S | |||||||
P. aeruginosa | R | R | R | R | R | R | R | R | R | S | |||||||||
Patient 3 | |||||||||||||||||||
S. aureus | R | S | S | S | S | S | S | S | R | ||||||||||
S. agalactiae | S | S | S | ||||||||||||||||
Patient 4 | |||||||||||||||||||
E. faecalis | S | R |
AMX: amoxicillin; TZP: piperacillin-tazobactam; CAZ: ceftazidime; FEP: cefepime; MEM: meropenem; LVX: levofloxacin; GEN: gentamicin; TOB: tobramycin; AMK: amikacin; ERY: erythromycin; CLI: clindamycin; SXT: trimethoprim-sulfamethoxazole; VAN: vancomycin; RIF: rifampicin; CST: colistin; OXA: oxacillin; LZD: linezolid; MIN: minocycline; PEN: penicillin; R: resistant strain; S: susceptible strain; I: susceptible strain, in case of increased exposure.